SAREPTA THERAPEUTICS INC (SRPT)
US8036071004 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to SRPT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 192.83. This target is 69.35% above the current price.
SRPT was analyzed by 29 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about SRPT.
In the previous month the buy percentage consensus was at a similar level.
SRPT was analyzed by 29 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-25 | HC Wainwright & Co. | Initiate | Sell |
| 2024-11-07 | Cantor Fitzgerald | Upgrade | Neutral -> Overweight |
| 2024-11-07 | Guggenheim | Maintains | Buy -> Buy |
| 2024-11-07 | Needham | Reiterate | Buy -> Buy |
| 2024-11-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-11-07 | Baird | Maintains | Outperform -> Outperform |
| 2024-10-21 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-10-21 | Jefferies | Initiate | Buy |
| 2024-10-14 | Needham | Reiterate | Buy -> Buy |
| 2024-10-10 | Raymond James | Reiterate | Outperform |
| 2024-10-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-09-20 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2024-09-19 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-09-06 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-08 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2024-08-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-08-08 | Barclays | Maintains | Overweight -> Overweight |
| 2024-08-08 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2024-08-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-08-08 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-07-29 | RBC Capital | Upgrade | Sector Perform -> Outperform |
| 2024-07-01 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-06-27 | Needham | Reiterate | Buy -> Buy |
| 2024-06-26 | Citigroup | Downgrade | Buy -> Neutral |
| 2024-06-24 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-06-24 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-06-24 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2024-06-24 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-06-21 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |